An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 215311
Company: STRIDES PHARMA

Products on ANDA 215311

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 215311

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/27/2022	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 215311

IBUPROFEN

SUSPENSION;ORAL; 100MG/5ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	074978	ACTAVIS MID ATLANTIC
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	209178	AUROBINDO PHARMA LTD
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	076925	PADAGIS US
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	215311	STRIDES PHARMA
IBUPROFEN	IBUPROFEN	100MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	209204	TARO

Top